@SomeGuy I used Wikipedia simply as an aggregator. Here are the refs:
…fructose is almost entirely metabolized in the liver in humans, where it is directed toward replenishment of liver glycogen and triglyceride synthesis.[1] pp. 258–277. Note: this is a ref to the book publisher, and I haven’t found an online version.
Under one percent of ingested fructose is directly converted to plasma triglyceride.[2]
29% - 54% of fructose is converted in liver to glucose, and about a quarter of fructose is converted to lactate [2] (ibid.).
15% - 18% is converted to glycogen.[3]
Glucose and lactate are then used normally as energy to fuel cells all over the body.[2]
In fact, ALL carbs do end up as glucose. But, you are correct, sir. Not all of sucrose ends up as glucose: <1% ends up as fatty acid to contribute to NAFLD, and <20% ends up as lactate, which is a breakdown product of glucose.
Source:
Hepatic Metabolism of Fructose. Outlined is the metabolism of a 20% fructose load as it passes through the liver. Fructose induces substrate-dependent phosphate depletion, thereby increasing uric acid. Fructose metabolism contributes to hypertension by inhibiting endothelial nitric oxide synthase and reducing nitric oxide (NO). Fructose also contributes to de novo lipogenesis (DNL), dyslipidemia, hepatic lipid droplet formation, and steatosis due to inadequate clearance of lipid produced during fructose metabolism. Fructose also contributes to muscle insulin resistance and activates mitogen-activated protein kinase/c-Jun N-terminal kinase (JNK-1), both of which are linked to hepatic insulin resistance. Hepatic insulin resistance promotes hyperinsulinemia and encourages metabolites to deposit into fat. Fructose increases forkhead box protein O1 (FOXO1), leading to gluconeogenesis and hyperglycemia and central nervous system (CNS) hyperinsulinemia. CNS hyperinsulinemia results in central leptin signaling upregulation and, in that way, stimulates continued energy intake. ACC, acetyl-CoA carboxylase; AMP, adenosine monophosphate; ApoB, apolipoprotein B; ChREBP, carbohydrate response element-binding protein; FFA, free fatty acid; Glut5, solute carrier family 2, facilitated glucose transporter member 5; Glut2, solute carrier family 2, facilitated glucose transporter member 2; Glut4, solute carrier family 2, facilitated glucose transporter member 4; LPL, lipoprotein lipase; PFK, phosphofructokinase; SREBP-1c, sterol regulatory element-binding protein 1c; VLDL, very-low-density lipoprotein.